Emergent BioSolutions
EBS
#8541
Rank
โ‚น24.69 B
Marketcap
โ‚น480.39
Share price
-6.36%
Change (1 day)
-45.11%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -โ‚น18.35 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚น0.62 Billion. In 2025 the company made an earning of โ‚น13.25 Billion, an increase over its 2024 earnings that were of -โ‚น6.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น18.35 Billion-238.42%
2025 โ‚น13.25 B-297.64%
2024 -โ‚น6.71 Billion-88.82%
2023 -โ‚น60.01 Billion242.73%
2022 -โ‚น17.51 Billion-153.8%
2021 โ‚น32.54 B-20.43%
2020 โ‚น40.90 B278.02%
2019 โ‚น10.82 B27.11%
2018 โ‚น8.51 B-27.12%
2017 โ‚น11.68 B17.21%
2016 โ‚น9.96 B0.45%
2015 โ‚น9.92 B73.51%
2014 โ‚น5.71 B41.36%
2013 โ‚น4.04 B35.2%
2012 โ‚น2.99 B0.4%
2011 โ‚น2.98 B-56.46%
2010 โ‚น6.84 B76.73%
2009 โ‚น3.87 B32.94%
2008 โ‚น2.91 B-5.62%
2007 โ‚น3.08 B
2005 โ‚น4.46 B269.89%
2004 โ‚น1.20 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น649.97 B-3,680.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น627.12 B-3,554.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น667.36 B-3,776.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น1.1 Billion-93.99%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-โ‚น1.04 Billion-94.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น30.4 Billion 67.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น114.17 B-728.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel